Cargando…
A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
CONTEXT: The combination of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) is widely used in the treatment of moderate-to-severe asthma uncontrolled by ICS alone. AIMS: To evaluate the efficacy and safety of a new ICS-LABA combination inhaler containing Formoterol (F) and Cicleso...
Autores principales: | Salvi, Sundeep S, Vaidya, Abhijit J, Kodgule, Rahul R, Gogtay, Jaideep A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857562/ https://www.ncbi.nlm.nih.gov/pubmed/27185990 http://dx.doi.org/10.4103/0970-2113.180803 |
Ejemplares similares
-
A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Barthwal, Madhu Sudan, et al.
Publicado: (2017) -
Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006) -
Is there a role for inhaled ciclesonide in the treatment of COVID-19?
por: Salvi, Sundeep Santosh
Publicado: (2021) -
Profile of ciclesonide for the maintenance treatment of asthma
por: Singas, Effie, et al.
Publicado: (2011) -
Efficacy of ciclesonide in the treatment of patients with asthma exacerbation
por: Zietkowski, Ziemowit, et al.
Publicado: (2019)